Form 4 for TDOC Teladoc Health, Inc.
Accepted 2024-06-04 00:00:00 ET · period of report 2024-05-31 · accession 0001477449-24-000155 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-06-04 | 2024-05-31 | TDOC | Murthy Mala | CFO, ACTING CEO | M - OptEx | — | +15.8K | 87.5K | +22% | — |
| D | 2024-06-04 | 2024-06-03 | TDOC | Murthy Mala | CFO, ACTING CEO | S - Sale+OE | $11.16 | -8,807 | 78.7K | -10% | -$98.3K |
| DM | 2024-06-04 | 2024-05-31 | TDOC | Murthy Mala | CFO, ACTING CEO | M - OptEx | $0.00 | -15.8K | 18.5K | -46% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-31 | M | A | 2,044 | — | 79,770 | D | — | — | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2024-06-03 | S | D | 8,807 | $11.16 | 78,713 | D | — | — | (F3) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| 3 | Common | Common Stock | 2024-05-31 | M | A | 2,641 | — | 74,357 | D | — | — | (F1) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 4 | Common | Common Stock | 2024-05-31 | M | A | 3,369 | — | 77,726 | D | — | — | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 5 | Common | Common Stock | 2024-05-31 | M | A | 7,750 | — | 87,520 | D | — | — | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 6 | Derivative | Restricted Stock Units | 2024-05-31 | M | D | 2,044 | $0.00 | 8,176 | D | — · — to — | 2,044 Common Stock | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F6) On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 7 | Derivative | Restricted Stock Units | 2024-05-31 | M | D | 3,369 | $0.00 | 10,107 | D | — · — to — | 3,369 Common Stock | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F5) On March 1, 2022, the reporting person was granted 40,426 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 8 | Derivative | Restricted Stock Units | 2024-05-31 | M | D | 7,750 | $0.00 | 54,254 | D | — · — to — | 7,750 Common Stock | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F7) On March 3, 2023, the reporting person was granted 93,006 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 9 | Derivative | Performance Stock Units | 2024-05-31 | M | D | 2,641 | $0.00 | 18,490 | D | — · — to — | 2,641 Common Stock | (F1) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. (F4) On March 1, 2024, the reporting person earned 31,696 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |